Wanbury

WANBURY02 May 2024

Pharmaceuticals

₹

-3.40 (-2.23%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Wanbury

Wanbury

Pharmaceuticals

WANBURY02 May 2024

₹

-3.40 (-2.23%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
28-May-2010	D	Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a dividend of Rs. 1/- per equity share for the financial year ended on March 31, 2010.	29-Jul-2010
31-Dec-2008	D	Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 31, 2008, inter alia, has recommended dividend of Rs 0.50 per equity shares i.e. @5% for the financial year 2007-2008 i.e. for the 18 months period ended as on September 30, 2008.	12-Mar-2009
29-Jun-2007	D	Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 29, 2007, inter alia, has recommended dividend of Rs 2 per equity share i.e. @ 20% for the financial year 2006-2007.	13-Sep-2007
01-Feb-2006	D	5% Interim Dividend	20-Feb-2006
27-Jun-2005	D	10% Dividend	28-Jul-2005
10-Apr-2024	BC	SBICAP Trustee Company Ltd	08-Apr-2024
01-Apr-2024	BC	Change in Management of the Company	31-Mar-2024
22-Mar-2024	BC	Expert Chemicals (India) Pvt Ltd	21-Mar-2024
21-Feb-2024	BC	Disclosure under Reg 30 of SEBI (LODR) Reg, 2015 for Completion of Tenure of Independent Director Revised Disclosures for change in management. (As per BSE Announcement Dated on 11/03/2024)	13-Feb-2024
12-Jan-2024	BC	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 o	24-Jan-2024

No Rights has been declared by WANBURY

Book Closure

Record Date	Split Date	Purpose
08-Apr-2024	-	SBICAP Trustee Company Ltd
31-Mar-2024	-	Change in Management of the Company
21-Mar-2024	-	Expert Chemicals (India) Pvt Ltd
13-Feb-2024	-	Disclosure under Reg 30 of SEBI (LODR) Reg, 2015 for Completion of Tenure of Independent Director Revised Disclosures for change in management. (As per BSE Announcement Dated on 11/03/2024)
24-Jan-2024	-	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 o

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Wanbury Ltd ₹149.30(-3.40/-2.23%)	149.30	-3.40	488.89	188.82	20.42	152.96
Astrazeneca Pharma India Ltd ₹5,333.85(-7.40/-0.14%)	5,333.85	-7.40	13,334.63	68.03	83.60	20.36
Bliss GVS Pharma Ltd ₹129.20(+5.50/4.45%)	129.20	+5.50	1,352.61	60.30	19.82	1.38
Cipla Ltd ₹1,419.55(+18.35/1.31%)	1,419.55	+18.35	114,613.75	52.94	34.85	4.43
Abbott India Ltd ₹26,604.35(+188.60/0.71%)	26,604.35	+188.60	56,534.24	18.05	49.35	18.18
Amrutanjan Health Care Ltd ₹786.60(+88.65/12.70%)	786.60	+88.65	2,274.11	15.18	51.68	8.68

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	145.50	144.46	146.29	132.98	125.78	123.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	145.50	144.46	146.29	132.98	125.78	123.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.69	0.76	0.62	-2.06	0.26	0.78
Total Income	146.19	145.22	146.90	130.91	126.04	124.74
Total Expenditure	124.35	127.12	132.94	119.41	119.32	118.36
PBIDT	21.84	18.10	13.96	11.51	6.72	6.38
Interest	8.26	7.67	5.79	7.51	6.63	3.94
PBDT	13.58	10.43	8.18	3.99	0.08	2.44
Depreciation	3.32	3.24	3.18	3.07	3.13	3.15
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.02	-0.18	0.30	-0.10	0.23	0.18
Reported Profit After Tax	10.27	7.36	4.69	1.02	-3.28	-0.89
Extra-ordinary Items	0.00	0.00	0.00	-0.59	0.00	0.00
Adjusted Profit After Extra-ordinary item	10.27	7.36	4.69	1.61	-3.28	-0.89

EPS (Unit Curr.)	3.14	2.25	1.43	0.31	-1.00	-0.27
EPS (Adj) (Unit Curr.)	3.14	2.25	1.43	0.31	-1.00	-0.27
Calculated EPS (Unit Curr.)	3.14	2.25	1.43	0.31	-1.00	-0.27
Calculated EPS (Adj) (Unit Curr.)	3.14	2.25	1.43	0.31	-1.00	-0.27
Calculated EPS (Ann.) (Unit Curr.)	12.55	9.00	5.73	1.24	-4.01	-1.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)	12.55	9.00	5.73	1.24	-4.01	-1.09
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	32.75	32.74	32.71	32.71	32.71	32.70
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.01	12.53	9.54	8.66	5.34	5.15
PBDTM(%)	9.33	7.22	5.59	3.00	0.06	1.97
PATM(%)	7.06	5.09	3.21	0.77	-2.61	-0.72

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	145.50	144.46	146.29	132.98	125.78	123.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	145.50	144.46	146.29	132.98	125.78	123.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.69	0.76	0.62	-2.06	0.26	0.78
Total Income	146.19	145.22	146.90	130.91	126.04	124.74
Total Expenditure	124.35	127.12	132.94	119.41	119.32	118.36
PBIDT	21.84	18.10	13.96	11.51	6.72	6.38
Interest	8.26	7.67	5.79	7.51	6.63	3.94
PBDT	13.58	10.43	8.18	3.99	0.08	2.44
Depreciation	3.32	3.24	3.18	3.07	3.13	3.15
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.02	-0.18	0.30	-0.10	0.23	0.18
Reported Profit After Tax	10.27	7.36	4.69	1.02	-3.28	-0.89
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	10.27	7.36	4.69	1.02	-3.28	-0.89

Extra-ordinary Items	0.00	0.00	0.00	-0.59	0.00	0.00
Adjusted Profit After Extra-ordinary item	10.27	7.36	4.69	1.61	-3.28	-0.89

EPS (Unit Curr.)	3.14	2.25	1.43	0.31	-1.00	-0.27
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	32.75	32.74	32.71	32.71	32.71	32.70

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.01	12.53	9.54	8.66	5.34	5.15
PBDTM(%)	9.33	7.22	5.59	3.00	0.06	1.97
PATM(%)	7.06	5.09	3.21	0.77	-2.61	-0.72

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	32.71	32.67	25.02	25.00	23.72	23.72
Reserves Total	-39.96	-30.48	-155.67	-142.83	-207.31	-182.74
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-7.25	2.19	-130.65	-117.83	-183.59	-159.02
Secured Loans	63.84	66.72	159.92	163.13	232.49	223.23
Unsecured Loans	4.43	6.88	5.64	0.50	0.50	0.50
Total Debt	68.27	73.60	165.56	163.63	232.99	223.73
Total Liabilities	61.02	75.79	34.91	45.80	49.40	64.71
APPLICATION OF FUNDS :
Gross Block	238.99	226.95	215.98	203.10	202.22	198.61
Less : Accumulated Depreciation	71.89	59.84	48.59	39.20	29.85	20.28
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	167.10	167.11	167.39	163.90	172.37	178.33
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.61	2.35	11.01	13.89	8.97	10.05
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.02	0.02
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	21.99	49.73	24.85	12.26	19.33	13.07
Sundry Debtors	67.98	62.80	34.47	50.79	44.41	29.46
Cash and Bank	3.89	25.27	11.66	16.66	5.22	6.18
Loans and Advances	26.67	31.89	24.97	8.67	24.03	23.79
Total Current Assets	120.54	169.69	95.96	88.38	92.99	72.50
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	223.11	258.49	234.34	216.30	221.05	192.55
Provisions	4.19	4.66	4.60	3.50	3.47	3.85
Total Current Liabilities	227.30	263.14	238.95	219.80	224.52	196.40
Net Current Assets	-106.77	-93.45	-142.99	-131.43	-131.53	-123.90
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	5.50	5.63	5.63	3.36	3.36	3.36
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	5.50	5.63	5.63	3.36	3.36	3.36
Total Assets	67.45	81.65	41.05	49.73	53.18	67.86
Contingent Liabilities	1071.74	933.78	889.00	1008.58	793.97	548.01

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	32.71	32.67	25.02	25.00	23.72	23.72
Reserves Total	-65.52	-56.09	-181.26	-168.45	-233.00	-208.40
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-32.81	-23.42	-156.24	-143.45	-209.28	-184.68
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	63.64	66.52	159.92	163.13	232.49	223.23
Unsecured Loans	31.29	33.74	32.30	27.16	27.16	27.16
Total Debt	94.93	100.26	192.22	190.29	259.65	250.39
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	13.93	12.07	13.75	11.56	10.69	10.14
Total Liabilities	76.05	88.91	49.73	58.40	61.06	75.85
APPLICATION OF FUNDS :
Gross Block	239.28	226.95	215.98	203.10	202.22	198.61
Less: Accumulated Depreciation	72.17	59.84	48.59	39.20	29.85	20.28
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	167.11	167.11	167.39	163.90	172.37	178.33
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.61	2.35	11.01	13.89	8.97	10.05
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.02	0.02
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	21.99	49.73	24.85	12.26	19.33	13.07
Sundry Debtors	67.98	62.80	34.47	50.79	44.41	29.46
Cash and Bank	3.93	25.31	11.70	16.70	5.25	6.21
Loans and Advances	28.26	33.40	26.51	10.16	25.43	25.23
Total Current Assets	122.16	171.24	97.53	89.90	94.42	73.96
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	223.63	258.98	234.85	216.79	221.51	193.01
Provisions	4.19	4.66	4.60	3.50	3.47	3.85
Total Current Liabilities	227.82	263.64	239.45	220.29	224.98	196.87
Net Current Assets	-105.66	-92.40	-141.92	-130.39	-130.56	-122.90
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	5.50	5.63	5.63	3.36	3.36	3.36
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	5.50	5.63	5.63	3.36	3.36	3.36
Other Assets	7.48	6.21	7.60	7.63	6.92	6.99
Total Assets
Contingent Liabilities	1071.74	933.78	889.25	551.43	368.99	548.01

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	22.49	9.96	2.62	2.71	2.84
Net Cash from Operating Activities	19.80	40.52	16.68	44.13	29.73
Net Cash Used In Investing Activities	-8.84	0.59	8.04	63.66	-3.07
Net Cash Used In Financing Activities	-31.99	-28.58	-17.39	-107.87	-26.78
Net Inc./Dec In Cash And Cash Equivalents	-21.03	12.53	7.34	-0.09	-0.13
Cash And Cash Equivalents At End Of The Year	1.46	22.49	9.96	2.62	2.71

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

39.79%

FII Shareholding

0.18%

DII Shareholding

0.00%

Public Shareholding

60.03%

**Promoter pledged shareholding 39.79%

About Wanbury Ltd

Wanbury Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 488.89 crores. It has reported a sales of Rs. 145.5 crores and a net profit of Rs. 10.27 crores for the quarter ended December 2018. The company management includes K Chandran, N K Puri,K Chandran,Jitendra J Gandhi,Pallavi Shedge,Pravin Dilip Pawar (Wanbury Ltd) among others.

Chairman

K Chandran

Registered office

BSEL Tech Park B-Wing 10th Flr,Sector 30 A Opp Vashi Rly Stat,Navi Mumbai,Maharashtra,400703

FAX :91-22-67942111/333

Background

Incorporation Year1988

Face Value₹10

Market Lot1

How to buy Wanbury shares on nse?

To buy Wanbury shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Wanbury share price today?

The Wanbury shares price on nse is Rs.149.3 today.

What is the market cap of Wanbury shares on BSE ?

The company has a market capitalization of Rs.488.89Cr

What is the PE & PB ratio of Wanbury shares ?

PE is 20.42 and PB is 152.96

What is the 52 Week High and Low of Wanbury shares?

Wanbury stock price high: Rs.177.4 Wanbury stock price low: Rs.41.2